JBZ-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JBZ-001, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies [Phase 1]